Manufacturer: Walter Bushnell
Salt Composition : Urofollitropin(150i.u)
Foligest 150I.U Injection is used in the treatment of female infertility. It is used in women who have a problem with ovulation or are undergoing fertility treatments like in-vitro fertilization.
Foligest 150I.U Injection is given as an injection under the supervision of a doctor. Your doctor or nurse will help you to learn the exact method of self-administration. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed with certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
The most common side effects of this medicine include pain in abdominal pain or cramp, headache, bloating, pelvic pain, nausea, hot flushes, and respiratory disorders. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.
Before taking this medicine, tell your doctor if you have ever had vaginal bleeding, or had an ovarian cyst, or tumor of the uterus. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are already pregnant or breastfeeding.
FSH, the active component of urofollitropin is the primary hormone responsible for follicular recruitment and development. FSH binds to the follicle stimulating hormone receptor which is a G-coupled transmembrane receptor.
Urofollitropin is a form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure. Urofollitropin is a urinary-derived follicle-stimulating hormone (FSH) that is extracted and purified from human urine samples
Abdominal pain
Headache
Bloating
Pelvic pain
Abdominal cramp
Nausea
Respiratory disorder
Hot flushes
Avoid taking UROFOLLITROPIN if you have tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries
Foligest 150I.U Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
It is unsafe to consume alcohol with Foligest 150I.U Injection.
Information regarding the use of Foligest 150I.U Injection during breastfeeding is not available. Please consult your doctor.
FertinexTM (urofollitropin for injection, purified) and hCG given in a sequential manner are indicated for the stimulation of follicular recruitment and development and the induction of ovulation in patients with polycystic ovary syndrome and infertility, who have failed to respond or conceive following adequate
Urofollitropin is used together with other medicines to treat infertility in women with FSH deficiency. Urofollitropin is also used to help the ovaries produce multiple eggs for use in "in-vitro" fertilization. Urofollitropin alone will not cause ovulation
Your doctor or nurse will give you this medicine.
Store in a refrigerator (2 - 8°C). Do not freeze.
If you miss a dose of Foligest 150I.U Injection, please consult your doctor.
Consult a doctor before taking any medicines
Your doctor may prescribe more than one medicine as part of a pregnancy plan.
The injection is administered under the skin. Follow the recommended dosage and monitoring schedules to minimise the possibility of ovarian hyperstimulation.
Inform your doctor immediately if you have severe pelvic pain, nausea, vomiting, diarrhea, sudden weight gain, trouble breathing, or decreased or no urination during treatment, as these could be symptoms of ovarian hyperstimulation syndrome (OHSS).
Do not use Foligest 150I.U Injection if you are already pregnant or breastfeeding.
Pregnancy following treatment with Foligest 150I.U Injection is more likely to result in a multiple pregnancy (twins or more) than if you had conceived naturally.
Foligest 150I.U Injection stimulates the production of eggs in women having treatment for anovulatory infertility.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Q. How and in what dose should I take Foligest 150I.U Injection?
It is given as an injection just under the skin by a medical healthcare professional only. The dose and treatment duration depends on your ovarian response for which you would be constantly monitored by your doctor during the treatment.
Q. What if I miss a dose of Foligest 150I.U Injection?
Ideally, you should try not to miss a dose of Foligest 150I.U Injection. However, please talk to your doctor as soon as you remember that you have missed a dose.
Q. What are the side effects of using Foligest 150I.U Injection?
The most common side effects are headache and pain in the abdomen. The other common side effects include hot flushes, nausea, vomiting, diarrhea, rashes and breast tenderness. If any of these side effects bother you, please consult with your doctor. In addition, this medicine may increase the likelihood of conditions like ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy.
Q. What is Foligest 150I.U Injection, and what is it used for?
Foligest 150I.U Injection contains a medicine called Urofollitropin. Urofollitropin is a type of follicle stimulating hormone (FSH). It helps to treat women who can not become pregnant because their ovaries do not produce eggs [including polycystic ovary disease (PCOD)]. It is also used in assisted reproductive technology (ART) procedures such as in-vitro fertilization (IVF), which help women to become pregnant.
